Category Archives: EUH

EUH Hunt Conference: What is the prognosis for adenocarcinoma of the lung?

The Bottom Line: There is an overall survival rate of less than 5 years. Stage I: 68-92% Stage II: 53-60% Stage III: 13-36% Stage IV: 0-10% Reference: DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 – . Record No. 114774, Non-small … Continue reading

Posted in EUH, Prognosis, Teaching pearls

EUH Hunt Conference: A review of Horner syndrome

The Bottom Line: Horner syndrome results from an interruption of sympathetic innervation to the eye. The classic triad is unilateral ptosis (slight narrowing of the ocular fissure), miosis (smaller pupil on the affected side), and anhidrosis (lack of perspiration on the … Continue reading

Posted in Background question, Diagnosis, EUH, Teaching pearls

EUH Hunt Conference: What is the prognosis for patients with HIV-negative PCNSL?

The Bottom Line: Patients diagnosed with primary central nervous system lymphoma (PCNSL) who are HIV-negative have a higher prognosis compared to those with PCNSL who are HIV-positive. While the median survival range is from 10-20 months for HIV-positive PCNSL patients, there … Continue reading

Posted in EUH, Prognosis

EUH Dressler Conference: A review of cardiac sarcoidosis

The Bottom Line: Cardiac sarcoidosis (CS) is the cardiac manifestations of sarcoidosis, a systemic disease of unknown cause characterized by immune granulomas. Cardiac involvement is clinically apparent in 5% of patients with sarcoidosis, but detected in approximately 20% of white and … Continue reading

Posted in Background question, EUH

EUH Krakow Conference: Review of Kikuchi-Fujimoto Disease

Bottom line: “Kikuchi–Fujimoto disease, or Kikuchi’s disease, also known as histiocytic necrotizing lymphadenitis, is a rare, benign, self‐limiting condition characterized by cervical lymphadenopathy and fever….symptoms usually resolve spontaneously within 1–4 months. However, cervical lymphadenopathy can persist for up to 6 months … Continue reading

Posted in Background question, EUH, Therapy

EUH Krakow Conference: Review of Lemierre’s Syndrome

Bottom Line: Vijay and Fattah1 state that Lemierre’s syndrome typically presents in young adults who were previously healthy. In a case series of 222 patients who fit the “Lemierre’s syndrome case presentation, the median age was 19 years and 89% of … Continue reading

Posted in Background question, Diagnosis, EUH, Therapy | Tagged

EUH Dressler Conference: Review of polymyositis

The Bottom Line: Inflammatory idiopathic myopathies (IIM) are a group of rare autoimmune diseases characterized by proximal skeletal muscle weakness, raised muscle enzymes and extramuscular organ involvement, most frequently the lungs, resulting in interstitial lung disease (ILD). Numerous autoantibodies are … Continue reading

Posted in EUH | Tagged ,